Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma

NCT01802138 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT01802138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01802138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma
Lead sponsor
Seoul National University Hospital
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2013
Completion date
October 31, 2018
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma